You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Dh334, a beta-carboline anti-cancer drug, inhibits the cdk activity of budding yeast
- In: SIG Pharmaceutical Biotechnology - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: PB-P-036
- By: LI, Yan (Institute of Medicinal Biotechnology, Beijing, China)
- Co-author(s): Liang, Feng Shan (Florida State University, TALLAHASSEE, United States of America)
Wang, Yanchang (Florida State University, TALLAHASSEE, United States of America)
Si, Shuyi (Institute of Medicinal Biotechnology, BEIJING, China) - Abstract:
The β-carboline alkaloids present in medicinal plants, such as Peganum harmala and Eurycoma longifolia, have recently drawn attention due to their antitumor activities. Further mechanistic studies indicate that β-carboline derivatives inhibit DNA topoisomerases and interfere with DNA synthesis. Moreover, some β-carboline compounds are..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026